Literature DB >> 12731670

Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells.

Xian Zhang1, Takashi Machii, Itaru Matsumura, Sachiko Ezoe, Akira Kawasaki, Hirokazu Tanaka, Shuji Ueda, Hiroyuki Sugahara, Hirohiko Shibayama, Masao Mizuki, Yuzuru Kanakura.   

Abstract

Hairy cell leukemia (HCL) is a rare type of chronic B-cell leukemia characterized by the hairy morphology of the leukemia cells. All of 5 HCL samples and an HCL-derived cell line, BNBH-I, showed serrated edges and hairlike projections in May-Grünwald Giemsa stain and protruding actin spikes and lamellipodia in phalloidin stain. These structures were hardly detected on B-cell chronic lymphocytic leukemia (B-CLL) and precursor B-cell acute lymphocytic leukemia (B-ALL) cells. Because Rho guanosine triphosphatases (GTPases) regulate the formation of these structures, we examined the expression levels and activation states of Rho GTPases in HCL cells. RhoA, Rac1, and Cdc42 were overexpressed and constitutively activated in HCL samples and BNBH-I cells but not in B-CLL or precursor B-ALL cells. Next we overexpressed dominant-negative (DN)-RhoA, DN-Rac1, and DN-Cdc42 in BNBH-I. As a result, each DN mutant repressed the growth of BNBH-I cells by more than 50% and inhibited actin spike formation, but only DN-Racl suppressed lamellipodia formation. We also found that enforced expression of constitutively active-RhoA, Rac, or Cdc42 in the proB-cell line Ba/F3 was sufficient to induce actin spike formation, whereas none of these molecules produced lamellipodia. These results indicated that constitutively activated Rho GTPases regulate the growth and unique morphology of HCL cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731670     DOI: 10.1007/bf02983784

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  38 in total

1.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

Authors:  A J Ridley; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

Review 2.  Rho GTPases.

Authors:  D J Mackay; A Hall
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

Review 3.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

4.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.

Authors:  T Ishizaki; M Uehata; I Tamechika; J Keel; K Nonomura; M Maekawa; S Narumiya
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

5.  The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.

Authors:  Y Tokumine; K Waki; Y Nishimori; H Kuratsune; R Inoue; Y Nakamura; E Ueda; T Machii; T Kitani
Journal:  Leukemia       Date:  1989-07       Impact factor: 11.528

6.  Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation.

Authors:  G M Doody; S E Bell; E Vigorito; E Clayton; S McAdam; R Tooze; C Fernandez; I J Lee; M Turner
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

7.  IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain.

Authors:  H Sakurai; H Chiba; H Miyoshi; T Sugita; W Toriumi
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

8.  rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation.

Authors:  D J Sulciner; K Irani; Z X Yu; V J Ferrans; P Goldschmidt-Clermont; T Finkel
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

9.  Hairy cell interactions with extracellular matrix: expression of specific integrin receptors and their role in the cell's response to specific adhesive proteins.

Authors:  J Burthem; P K Baker; J A Hunt; J C Cawley
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

10.  Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine.

Authors:  G Juliusson; R Lenkei; J Liliemark
Journal:  Blood       Date:  1994-06-15       Impact factor: 22.113

View more
  6 in total

Review 1.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells.

Authors:  Benjamin Chaigne-Delalande; Lynda Deuve; Edith Reuzeau; Caroline Basoni; David Lafarge; Christine Varon; Florence Tatin; Guerric Anies; Richard Garand; Ijsbrand Kramer; Elisabeth Génot
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemia.

Authors:  Joseph R Slupsky; Aura S Kamiguti; Robert J Harris; John C Cawley; Mirko Zuzel
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 4.  Hairy cell leukemia: update and current therapeutic approach.

Authors:  Latif Salam; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 5.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

Review 6.  Dual effect of oxidative stress on leukemia cancer induction and treatment.

Authors:  Udensi K Udensi; Paul B Tchounwou
Journal:  J Exp Clin Cancer Res       Date:  2014-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.